Jim Alfaro has joined JMP Securities as a managing director, healthcare investment banker, after a nearly 15-year stint with Maxim Group.

Kee Colen has joined Cantor Fitzgerald as a managing director, healthcare investment banking, from Raymond James.

Evert Schimmelpennink Closely-held Pipeline Therapeutics named Evert (Eef) Schimmelpennink to its board. Mr. Schimmelpennink is a seasoned biotechnology executive with close to 25 years of experience spanning research...

In-network psychiatric care provider, Talkiatry, appointed Vanessa Cao as SVP of operations as the company prepares for a national rollout. With more than 10 years of experience in operations, Ms. Cao joins Talkiatry...

Hope Frank Closely-held Labster, a virtual learning platform for students, named Hope Frank as chief marketing officer as part of its continued mission to bring accessible and transformative STEM education (science...

Ezekiel Emanuel Closely-held cell therapy manufacturer, Cellares, appointed Ezekiel Emanuel, M.D. and Ph.D., to its board of advisors. Dr. Emanuel is a bioethicist and currently vice provost for global initiatives, the...

Closely-held GeneTether, a genome editing technology company, named Roland Boivin as CEO, Jean Jen as CFO and Peter Sampson, Ph.D., as VP of research and development.  The appointments are intended to further position...

Kyle Mikson Canaccord Genuity appointed Kyle Mikson as a director, senior equity research analyst covering the life science tools and diagnostics sector.  Mr. Mikson will focus on expanding the firm’s footprint on...